Your browser is no longer supported. Please, upgrade your browser.
NUVA NuVasive, Inc. daily Stock Chart
NuVasive, Inc.
Index- P/E108.70 EPS (ttm)0.62 Insider Own0.50% Shs Outstand51.08M Perf Week6.31%
Market Cap3.45B Forward P/E27.60 EPS next Y2.45 Insider Trans-11.13% Shs Float50.33M Perf Month-14.08%
Income35.70M PEG7.46 EPS next Q0.50 Inst Own- Short Float13.88% Perf Quarter-5.11%
Sales1.02B P/S3.38 EPS this Y-45.70% Inst Trans-0.50% Short Ratio7.55 Perf Half Y-9.22%
Book/sh14.07 P/B4.81 EPS next Y22.44% ROA2.20% Target Price80.71 Perf Year6.81%
Cash/sh- P/C- EPS next 5Y14.58% ROE5.10% 52W Range56.70 - 81.68 Perf YTD0.37%
Dividend- P/FCF28.43 EPS past 5Y19.10% ROI7.10% 52W High-17.22% Beta1.08
Dividend %- Quick Ratio1.40 Sales past 5Y12.20% Gross Margin75.10% 52W Low19.24% ATR1.98
Employees2200 Current Ratio2.40 Sales Q/Q10.30% Oper. Margin10.20% RSI (14)41.54 Volatility2.87% 2.68%
OptionableYes Debt/Eq0.91 EPS Q/Q-61.80% Profit Margin3.50% Rel Volume1.00 Prev Close68.00
ShortableYes LT Debt/Eq0.80 EarningsJul 27 AMC Payout0.00% Avg Volume924.43K Price67.61
Recom2.00 SMA20-3.94% SMA50-9.46% SMA200-5.26% Volume919,429 Change-0.57%
Jul-28-17Downgrade Robert W. Baird Outperform → Neutral $79 → $72
Jun-06-17Reiterated RBC Capital Mkts Outperform $76 → $85
Nov-30-16Initiated Aegis Capital Buy $72
Jul-27-16Reiterated Barclays Overweight $63 → $71
Jul-13-16Upgrade JP Morgan Neutral → Overweight $55 → $74
May-27-16Upgrade Barclays Equal Weight → Overweight $58 → $63
Dec-11-15Upgrade BofA/Merrill Underperform → Neutral
Oct-06-15Upgrade Canaccord Genuity Hold → Buy $52 → $58
Sep-14-15Initiated Morgan Stanley Equal-Weight $60
Jul-29-15Upgrade Northland Capital Market Perform → Outperform $68
Jul-29-15Reiterated Barclays Equal Weight $54 → $56
Jun-03-15Downgrade Goldman Buy → Neutral
May-14-15Initiated Northland Capital Market Perform $46
Apr-15-15Downgrade Canaccord Genuity Buy → Hold $54 → $49
Feb-25-15Reiterated Brean Capital Buy $53 → $55
Jan-13-15Reiterated WallachBeth Buy $49 → $55
Jan-08-15Upgrade RBC Capital Mkts Sector Perform → Outperform $45 → $56
Dec-04-14Reiterated Brean Capital Buy $44 → $53
Sep-30-14Upgrade Brean Capital Hold → Buy $44
May-21-14Downgrade Needham Buy → Hold
Aug-16-17 08:06AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Aug-15-17 07:30AM  NuVasive Appoints Rajesh J. Asarpota As Chief Financial Officer PR Newswire
Aug-14-17 05:04PM  ETFs with exposure to NuVasive, Inc. : August 14, 2017 Capital Cube
08:06AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Aug-12-17 08:20PM  Edited Transcript of NUVA earnings conference call or presentation 27-Jul-17 8:30pm GMT Thomson Reuters StreetEvents
08:05AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Aug-09-17 08:06AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Aug-02-17 01:10PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of NuVasive Inc. (NUVA) PR Newswire
Jul-31-17 01:41PM  NuVasive, Inc. :NUVA-US: Earnings Analysis: Q2, 2017 By the Numbers : July 31, 2017 Capital Cube
09:07AM  NuVasive (NUVA) Beats on Q2 Earnings, Retains 2017 View Zacks
Jul-28-17 12:49PM  Here's Why NuVasive Is Tanking Today Motley Fool -12.73%
09:40AM  NuVasive, Inc. breached its 50 day moving average in a Bearish Manner : NUVA-US : July 28, 2017 Capital Cube
12:28AM  NuVasive beats 2Q profit forecasts Associated Press
Jul-27-17 09:57PM  Executive Changes Hit NuVasive Hard Motley Fool
05:09PM  NuVasive shares drop after announced COO, CFO departures MarketWatch
04:05PM  NuVasive Announces New Organizational Structure To Drive Growth And Profitability Goals PR Newswire
04:02PM  NuVasive Reports Second Quarter 2017 Financial Results PR Newswire
11:15AM  Investor Network: NuVasive, Inc. to Host Earnings Call ACCESSWIRE
Jul-10-17 04:19PM  NuVasive, Inc. Value Analysis (NASDAQ:NUVA) : July 10, 2017 Capital Cube
04:05PM  NuVasive Leading Sponsor Of IMAST 2017 And Hosting Workshops Featuring Advanced Technologies PR Newswire
Jul-07-17 09:41AM  NuVasive, Inc. breached its 50 day moving average in a Bearish Manner : NUVA-US : July 7, 2017 Capital Cube
Jul-05-17 04:05PM  NuVasive Announces Conference Call And Webcast Of Second Quarter 2017 Results PR Newswire
Jun-28-17 08:51AM  NuVasive (NUVA) Grappling with Odds: Should You Dump Stock? Zacks
Jun-12-17 09:43AM  NuVasive (NUVA) at 52-Week High: What's Driving the Stock? Zacks
Jun-05-17 07:05AM  NuVasive Magnetic, Non-Invasive Platforms Featured In The Journal Of Orthopaedic Trauma Supplement PR Newswire
Jun-01-17 07:05AM  NuVasive Appoints Skip Kiil As Executive Vice President, International PR Newswire
May-30-17 12:36PM  ETFs with exposure to NuVasive, Inc. : May 30, 2017 Capital Cube
09:07AM  NuVasive Aims for Innovation, Global Growth amid Woes Zacks
May-26-17 08:14AM  NuVasive, Inc. breached its 50 day moving average in a Bullish Manner : NUVA-US : May 26, 2017 Capital Cube
May-22-17 07:00AM  NuVasive Announces Educational Initiatives In Support Of Spine's Fastest Growing Spinal Deformity Portfolio PR Newswire
May-09-17 04:05PM  NuVasive To Present At Bank of America Merrill Lynch 2017 Global Healthcare Conference PR Newswire
May-08-17 05:00PM  ETFs with exposure to NuVasive, Inc. : May 8, 2017 Capital Cube
May-02-17 04:05PM  NuVasive Announces Sponsorship Of EPOSNA 2017 And Launches New Monthly Pediatric Spinal Deformity Podcast PR Newswire
Apr-29-17 07:24AM  Edited Transcript of NUVA earnings conference call or presentation 25-Apr-17 8:30pm GMT Thomson Reuters StreetEvents
Apr-28-17 04:08PM  ETFs with exposure to NuVasive, Inc. : April 28, 2017 Capital Cube
Apr-27-17 11:03AM  NuVasive, Inc. :NUVA-US: Earnings Analysis: Q1, 2017 By the Numbers : April 27, 2017 Capital Cube
Apr-26-17 08:46AM  NuVasive (NUVA) Beats on Q1 Earnings, Retains 2017 View Zacks
Apr-25-17 06:28PM  NuVasive Straightens Up With Solid Growth Motley Fool
04:46PM  NuVasive beats 1Q profit forecasts Associated Press
04:05PM  NuVasive Announces First Quarter 2017 Financial Results PR Newswire
07:20AM  Heres how much NuVasives 5 highest-paid executives earned American City Business Journals
Apr-24-17 09:35AM  Lawsuit for Investors in NASDAQ:NUVA Shares against Directors of NuVasive, Inc Announced by Shareholders Foundation Accesswire
Apr-21-17 03:42PM  NuVasive, Inc. Value Analysis (NASDAQ:NUVA) : April 21, 2017 Capital Cube
07:42AM  NuVasive (NUVA) Q1 Earnings: Disappointment in the Cards? Zacks
Apr-20-17 04:05PM  NuVasive Unveils New Trauma Portfolio And Virtual Reality Simulation At AANS 2017 PR Newswire
04:02PM  NuVasive launching products to hit $100M market American City Business Journals
08:20AM  NuVasive, Inc. breached its 50 day moving average in a Bullish Manner : NUVA-US : April 20, 2017 Capital Cube
Apr-19-17 04:05PM  NuVasive Launches New Spinal Trauma Portfolio PR Newswire
Apr-12-17 08:00AM  NuVasive To Feature Proprietary Radiation Reduction Platform At ISASS 2017 PR Newswire
Apr-10-17 04:05PM  NuVasive Announces Conference Call And Webcast Of First Quarter 2017 Results PR Newswire
Apr-06-17 08:30AM  NuVasive, Inc. breached its 50 day moving average in a Bearish Manner : NUVA-US : April 6, 2017 Capital Cube
Apr-03-17 09:03AM  NuVasive Receives FDA 510(k) Clearance in Cervical Spine Zacks
Mar-30-17 09:13AM  NuVasive (NUVA) Gets FDA 510(k) Clearance for CoRoent System Zacks
09:13AM  NuVasive (NUVA) Gets FDA 510(k) Clearance for CoRoent System at Investopedia
Mar-29-17 09:00AM  NuVasive Receives First-Ever FDA Clearance For Cervical Interbody Implant System Used In More Than Two Levels PR Newswire
Mar-20-17 09:00AM  New Evidence-Based Recommendation Released From NICE (U.K.) For Lateral Interbody Fusion PR Newswire
Mar-15-17 06:52AM  Why Is NuVasive (NUVA) Up 3.1% Since the Last Earnings Report? Zacks
Mar-02-17 05:34PM  NuVasive to Participate in Investor Events in March 2017 PR Newswire
08:25AM  RBC Says These Top Health Care Stocks Could Be 2017 Takeover Candidates 24/7 Wall St.
Mar-01-17 02:46PM  Jana Partners' Largest 4th-Quarter Buys
Feb-28-17 04:30PM  Masimo's Stock Is a Great Buy Right Now
Feb-15-17 01:04PM  NUVASIVE INC Financials
Feb-14-17 05:22PM  Bets on financials, pharma power U.S. hedge funds' strong start to year Reuters
12:35PM  NuVasive, Inc. :NUVA-US: Earnings Analysis: 2016 By the Numbers : February 14, 2017
Feb-13-17 09:24AM  NuVasive, Inc. :NUVA-US: Earnings Analysis: Q4, 2016 By the Numbers : February 13, 2017
Feb-10-17 07:36AM  NuVasive (NUVA) Beats Q4 Earnings, Revenues; Guides 2017
Feb-09-17 10:45PM  Edited Transcript of NUVA earnings conference call or presentation 9-Feb-17 9:30pm GMT
07:35PM  NuVasive Builds Momentum Going Into 2017 at Motley Fool
05:53PM  NuVasive tops Street 4Q forecasts
04:30PM  NuVasive Inc Earnings Call scheduled for 4:30 pm ET today
04:14PM  NUVASIVE INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial S
04:05PM  NuVasive Reports Fourth Quarter And Full Year 2016 Financial Results PR Newswire
11:56AM  Manufacturer hiring 200+ at Dayton-area facility at
07:07AM  Q4 2016 NuVasive Inc Earnings Release - After Market Close
Feb-07-17 08:44AM  Why NuVasive (NUVA) Might Surprise This Earnings Season
Feb-06-17 08:30AM  NuVasive To Present At Leerink Partners 6th Annual Global Healthcare Conference 2017 PR Newswire
Jan-13-17 11:41AM  NuVasive Announces Conference Call and Webcast of Fourth Quarter 2016 Results Marketwired
Jan-12-17 10:37AM  Johnson & Johnsons Expandable Cage Acquisition to Accelerate the Spine Division
06:46AM  NuVasive at 52-Week High on Preliminary Results, MHLW Nod
Jan-09-17 01:52PM  ETFs with exposure to NuVasive, Inc. : January 9, 2017
08:00AM  NuVasive Announces Select Preliminary Unaudited Full Year 2016 Financial Results and 2017 Outlook Marketwired
07:51AM  NUVASIVE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Jan-04-17 04:05PM  NuVasive to Present at the 35th Annual J.P. Morgan Healthcare Conference Marketwired
Dec-30-16 08:28AM  NuVasive (NUVA) Wins MHLW Approval for XLIF Device Suite
Dec-29-16 07:05AM  NuVasive to Resume XLIF Procedures in Japan in First Quarter 2017 Marketwired
Dec-16-16 12:00PM  ETFs with exposure to NuVasive, Inc. : December 16, 2016
Dec-02-16 07:45AM  NuVasive, Inc. breached its 50 day moving average in a Bearish Manner : NUVA-US : December 2, 2016
Dec-01-16 10:45AM  Is NuVasive, Inc. (NUVA) a Good Stock To Buy? at Insider Monkey
07:00AM  NuVasive to Showcase Integrated Global Alignment for the Cervical Spine at CSRS 2016 Marketwired
Nov-30-16 12:46PM  ETFs with exposure to NuVasive, Inc. : November 30, 2016
07:14AM  Coverage initiated on NuVasive by Aegis Capital
Nov-29-16 09:14AM  NuVasive: Q3 Results Lack Shine, Spine Market Holds Promise
Nov-28-16 05:27PM  NUVASIVE INC Files SEC form 8-K, Other Events
Nov-26-16 01:53PM  Lions Gate Entertainment Corp. (USA) (LGF): Are Hedge Funds Right To Abandon This Stock? at Insider Monkey
Nov-21-16 02:38PM  Krush Technologies takes home top honor at 2016 DBJ Business of the Year Awards at
07:09AM  NuVasive, Inc. breached its 50 day moving average in a Bullish Manner : NUVA-US : November 21, 2016
Nov-18-16 01:25PM  ETFs with exposure to NuVasive, Inc. : November 18, 2016
Nov-17-16 08:36PM  NuVasive to Participate in the Piper Jaffray 28th Annual Healthcare Conference Marketwired
Nov-16-16 09:36AM  2 Stocks That Quadrupled Over the Past 5 Years at Motley Fool
Nov-11-16 10:00AM  JobsOhio commits $1M to companies promising 395 jobs at
NuVasive, Inc., a medical device company, develops and markets minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery. Its products focus on applications for spine fusion surgery, including biologics used for spinal fusion process. The company's principal product is Maximum Access Surgery, a minimally-disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, NVM5, and intraoperative monitoring (IOM) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics. Its spine surgery product line offerings comprise products for the thoracolumbar and the cervical spine, which are primarily used to enable surgeons access to the spine and to perform restorative and fusion procedures in a minimally-disruptive fashion. Its biologics products include Osteocel Plus and Pro, a cellular bone matrix; Formagraft, a collagen-based synthetic bone substitute; AttraX, a synthetic bone graft material; and Propel DBM, a moldable demineralized bone matrix putty, which are used for spinal fusion or bone healing process. The company's IOM services are used for onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. It also provides implants; and fixation products, including pedicle screws, rods, and plates. In addition, the company offers Integrated Global Alignment platform for assessing, preserving, and restoring spinal alignment; MAGEC-early onset scoliosis, a spinal bracing and distraction system; and PRECICE, a limb lengthening system. NuVasive, Inc. sells its products to hospitals, surgeons, and other customers through independent sales agents, directly-employed sales personnel, and distributors in the United States and internationally. The company was founded in 1997 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Leddy Peter MichaelEVP Global HRAug 01Option Exercise0.002,265014,601Aug 03 05:58 PM
Carol CoxEVP External AffairsAug 01Option Exercise0.004,465014,577Aug 03 05:56 PM
Leddy Peter MichaelEVP Global HRAug 01Buy63.887,850501,48712,336Aug 03 05:58 PM
Sylvain Jereme MChief Accounting OfficerJul 01Option Exercise0.002,09108,177Jul 05 05:53 PM
Miles PatrickDirectorJun 07Sale78.3515,0001,175,25072,756Jun 09 05:56 PM
OHALLERAN MICHAEL DDirectorMay 18Option Exercise0.001,890010,295May 22 05:54 PM
Miles PatrickDirectorMay 01Option Exercise0.005,599090,677May 03 05:55 PM
Hannon JasonPresident and COOMar 08Sale74.2224,8401,843,67144,961Mar 09 06:03 PM
Hannon JasonPresident and COOMar 07Option Exercise34.8297,3753,390,598142,336Mar 09 06:03 PM
Link MatthewPresident, U.S. CommercialMar 01Option Exercise0.001,250083,067Mar 03 05:57 PM
Miles PatrickDirectorMar 01Option Exercise0.006,001087,780Mar 03 05:51 PM
LUCIER GREGORY TChairman & CEOFeb 14Sale72.7817,2861,258,075112,996Feb 16 05:56 PM
HOWE LESLEY HDirectorFeb 14Sale73.266,049443,15011,830Feb 15 05:57 PM
HOWE LESLEY HDirectorFeb 13Option Exercise36.5812,000438,90023,830Feb 15 05:57 PM
Sylvain Jereme MChief Accounting OfficerFeb 01Option Exercise0.0093106,064Feb 03 06:03 PM
Miles PatrickDirectorFeb 01Option Exercise0.0024,486092,602Feb 03 06:01 PM
Link MatthewPresident, U.S. CommercialFeb 01Option Exercise0.0018,384091,198Feb 03 05:57 PM
LUCIER GREGORY TChairman & CEOFeb 01Option Exercise0.0013,9980135,681Feb 03 05:58 PM
Hannon JasonPresident and COOFeb 01Option Exercise0.0019,432054,817Feb 03 05:55 PM
Carol CoxEVP Ext Affairs & Corp MktgFeb 01Option Exercise0.001,929010,493Feb 03 05:53 PM
Blackford Quentin S.CFOFeb 01Option Exercise0.008,531024,270Feb 03 05:50 PM
Blackford Quentin S.CFOJan 01Option Exercise0.005,924019,332Jan 04 06:00 PM
Link MatthewPresident, U.S. CommercialJan 01Option Exercise0.0012,936080,784Jan 04 05:54 PM
Link MatthewPresident, U.S. CommercialDec 12Sale67.9910,303700,50168,030Dec 14 05:57 PM
OHALLERAN MICHAEL DDirectorNov 04Buy58.264,200244,6928,405Nov 08 05:48 PM
Miles PatrickDirectorNov 02Buy57.4130017,22316,967Nov 02 05:53 PM
Miles PatrickDirectorNov 01Buy59.0016,667983,27816,677Nov 02 05:53 PM
FARRELL PETER CDirectorOct 31Option Exercise25.306,000151,80021,187Nov 02 05:49 PM
Stafslien JoanEVP and General CounselOct 31Buy59.685,000298,4005,000Nov 02 06:03 PM
OHALLERAN MICHAEL DDirectorOct 31Buy59.474,205250,0714,205Nov 02 05:56 PM
Link MatthewPresident, U.S. CommercialOct 01Option Exercise0.001,250078,985Oct 04 05:59 PM
Hannon JasonEVP, InternationalAug 23Option Exercise34.822,62591,40338,010Aug 24 06:42 PM
Hannon JasonEVP, InternationalAug 23Sale64.802,625170,10035,385Aug 24 06:42 PM